Unresectable pancreatic adenocarcinoma with full clinical response following chemoradiotherapy

Locally advanced or metastatic disease is present in 2/3s of patients with pancreatic cancer. Pancreatic cancer patients are assessed as resectable, potentially resectable (borderline) and unresectable according to pre-operative examinations. The chance for operability may be enhanced by using adjuv...

Full description

Saved in:
Bibliographic Details
Published in:Turkish journal of surgery 2015-03, Vol.31 (1), p.49
Main Authors: Aksoy, Erol, Ulas, Murat, Muhammet Kadri Çolakoglu, Özer, Ilter, Erdal Birol Bostanci, Akoglu, Musa
Format: Article
Language:English
Subjects:
Biopsy
Cancer therapies
Chemotherapy
Family medical history
Medical prognosis
Pancreatic cancer
Patients
Postoperative period
Radiation therapy
Tumors
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Locally advanced or metastatic disease is present in 2/3s of patients with pancreatic cancer. Pancreatic cancer patients are assessed as resectable, potentially resectable (borderline) and unresectable according to pre-operative examinations. The chance for operability may be enhanced by using adjuvant-neoadjuvant systemic chemotherapy, radiotherapy or both. The rates of R0 resection may be increased by means of treatment delivered this way. This case report presents a pancreatic adenocarcinoma case that was assessed to be resectable but was identified to be unresectable during surgical exploration, thus received adjuvant chemoradiotherapy. The patient was then re-evaluated, identified as resectable and received pancreaticoduodenectomy.
ISSN:2564-6850
2564-7032
DOI:10.5152/UCD.2014.2210